NRG-GU006 trial for post-prostatectomy radiation therapy. Daniel Spratt, MD Case Comprehensive Cancer Center joins Jeff Michalski, MD, MBA, FACR, FASTRO Washington University in St. Louis to present the NRG GU006/BALANCE trial results, demonstrating PAM50 molecular subtypes as the first prospectively validated predictive biomarker guiding hormone therapy decisions in recurrent #ProstateCancer. #WatchNow on UroToday > bit.ly/4mONYa3 | UroToday

1.4M views · 28K reactions | I recognize myself in their eyes. Translation: Day by day we walk on, Our feet pressing The same earth Our fathers and our fathers’ fathers Walked day by day, While they walked on. Day by day we walk on, Hush, little ones, Don’t tell the earth We love her yet. We will sleep in her soon enough, But for now we walk on. Video via @@danielhansonmusic #mamuna #mamunatribe #southpapua | Daniel DiPiazza | Facebook